Urinary Tract Infections Clinical Trial
— ES-Stimquick UOfficial title:
Quick-Wee Versus Bladder Stimulation to Collect Midstream Urine From Pre-continent Infants: a Randomized Controlled Trial
Verified date | September 2023 |
Source | Fondation Lenval |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Urinary tract infections are common in infants. Obtaining urine from pre-continent children can be difficult and time consuming. The method of collection must balance reliability, speed, low rate of contamination, and invasiveness. According to the American Academy of Pediatrics, midstream clean-catch urine is an acceptable method to diagnose urinary tract infections. However, it is impractical in pre-continent children. Recently, two quick, safe and effective methods have been reported in the literature: - The Quick-wee method: it consists in stimulating the suprapubic area with a cold and wet compress to obtain urines. - The bladder stimulation method : the child is held under the armpits with legs dangling and a physician taps the suprapubic area and massages lumbar area alternatively. However, advanced age, high weight, and level of discomfort during bladder stimulation were significantly associated with failure to obtain urines.
Status | Completed |
Enrollment | 230 |
Est. completion date | November 17, 2022 |
Est. primary completion date | June 6, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 1 Year |
Eligibility | Inclusion Criteria: - Infants under the age of 1 year, pre-continent, before walking - For whom an urine sample is required for the diagnosis of a urinary tract infection, uropathy, nephropathy, metabolic disease - Obtaining the authorization by one of the two parents or the holder of parental authority - Affiliation to a national social security scheme Exclusion Criteria: - Do exhibiting signs of vital distress - Withdrawal of informed consent by parents or holders of parental authority - External genitalia or urinary tract malformation - Bladder dysfunction |
Country | Name | City | State |
---|---|---|---|
Canada | Centre Hospitalier Universitaire de Sainte-Justine | Montréal | |
France | Centre Hospitalier Antibes Juan les Pins | Antibes | |
France | Hôpitaux Pédiatriques de Nice CHU-Lenval | Nice |
Lead Sponsor | Collaborator |
---|---|
Fondation Lenval |
Canada, France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | volume of urine collection to measure the effectiveness of two techniques | measure of success of the urine collection technique is determined by collecting at least 2 millimeters of urine in less than 5 minutes | at the end of intervention completion, an average 30 minutes | |
Secondary | time needed to obtain urines | measure of times needed to obtain urines in minutes and seconds | at the end of intervention completion, an average 30 minutes | |
Secondary | patient comfort | pain is measured by Evaluation ENfant DOuLeur (EVENDOL) scale while the technique is performed. EVENDOL is a pain scale for children under 7. A pain scale validated for children from birth to 7 years. Score ranges from 0 to 15.
Treatment threshold: 4/15. |
through intervention completion, an average 30 minutes | |
Secondary | Bacterial contamination rates of urine samples | Measure of bacterial contamination of urine sample is by:
numeration the growth of two or more micro-organisms, Or numeration the presence of a non-uropathogenic germ (lactobacilli, Staphylococcus Coagulase negative, Corynebacterium), or numeration a bacteriuria> 0 colony forming unit(CFU)/millimeters (mL) but <10^4 CFU / ml for bladder catheterization and <10^5 CFU / mL for clean catch urine collected by bladder stimulation, or leukocyturia <10^4 / mL |
at 48 hours after inclusion | |
Secondary | collection of patient data to define risk factors associated with the failure of the bladder stimulation techniques | collection patient data : pain, weight, sex, age, last food and time since last collect urine The goal is to define potential risk factors to failure urine collection (urinary sample quantity < 2 millimeters or no urinary sample collected) | through intervention completion, an average 30 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04495699 -
Asymptomatic Renal Calculi in Recurrent Urinary Tract Infections
|
||
Terminated |
NCT05254808 -
EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care
|
Phase 3 | |
Completed |
NCT03680612 -
Cefepime/AAI101 Phase 2 Study in Hospitalized Adults With cUTI
|
Phase 2 | |
Completed |
NCT03282006 -
Treating Pyelonephritis an Urosepsis With Pivmecillinam
|
Phase 4 | |
Completed |
NCT03526484 -
The Utility of Urinalysis Prior to In-Office Procedures
|
N/A | |
Completed |
NCT05397782 -
Effects of Flourish on Recurrent Urinary Tract Infection
|
N/A | |
Completed |
NCT05018546 -
Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery
|
N/A | |
Completed |
NCT03687255 -
Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections
|
Phase 3 | |
Recruiting |
NCT05227937 -
Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study
|
||
Completed |
NCT02864420 -
Hospitalization at Home: The Acute Care Home Hospital Program for Adults
|
N/A | |
Completed |
NCT03131609 -
Avoiding Bacterial Contamination of Clean Catch Urine Cultures in Ambulatory Patients in the Emergency Department
|
||
Completed |
NCT01911143 -
A Retrospective, Blinded Validation of a Host-response Based Diagnostics
|
N/A | |
Completed |
NCT01333254 -
A Trial of Different Methods for Bladder Drainage in Hip Surgery Patients
|
N/A | |
Terminated |
NCT00594594 -
Adjuntive Probiotic Therapy in Treating Urinary Tract Infections in Spinal Cord Injury
|
Phase 1 | |
Completed |
NCT00216853 -
A Study of Vaginal MicroFlora and Immune Profiles of Patients With Recurrent Urinary Tract Infection
|
N/A | |
Completed |
NCT00787085 -
The Significance of Funguria in Hospitalized Patients
|
N/A | |
Completed |
NCT05719753 -
The Effectiveness of a Bacteriophobic Coating on Urinary Catheters
|
N/A | |
Recruiting |
NCT05415865 -
The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder
|
Phase 3 | |
Not yet recruiting |
NCT05880329 -
DIagnoSing Care hOme UTI Study
|
||
Recruiting |
NCT04615065 -
Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
|